← Leaderboards
Jeffrey L Blumer
Case Western Reserve University
$4,676,143
Attributed
$4,676,143
Total exposure
8
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $399.2K · FY2005–09$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$4,676,143 · 8
By mechanism
U10$2,247,330 · 1
U01$1,968,732 · 1
R21$421,683 · 1
M01$38,398 · 3
N01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at Case Western Reserve University
Same institution · by research overlap
- John J Pink$2,581,828
- Stanton L Gerson$68,151,957
- William T Dahms$2,935,366
- Rong Xu$12,893,861
- Pamela B Davis$114,848,546
Others in their field
Top investigators on “Pediatric Pharmacology”
- Garret A Fitzgerald · University Of Pennsylvania$125,310,120
- Stephen A Spector · University Of California, San Diego$84,289,331
- Gregory H Reaman · National Childhood Cancer Foundation$80,145,837
- Constance Ann Benson · University Of California, San Diego$65,790,143
- David Eric Shapiro · Harvard University D/B/A Harvard School Of Public Health$63,773,218
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$57,671,528
Research focus
Pediatric PharmacologyHuman SubjectPharmacokineticsClinical ResearchChild (0-11)Human Therapy EvaluationClinical TrialsDrug Screening /EvaluationDrug Adverse EffectPharmacogeneticsPediatricsCooperative StudyAge DifferenceDrug MetabolismSleep DisordersGastrointestinal AgentsGastrointestinal Disorder ChemotherapyPhenytoinConstipationAntihypertensive AgentsBiological AvailabilityAdolescence (12-20)Clinical DataCritical Illness
Grant awards (25)
Pediatric Pharmacology Research Unit$273,420
U10 · FY2009 · HD · contact PI
Pediatric Pharmacology Research Unit$397,745
U10 · FY2008 · HD · contact PI
Pediatric Pharmacology Research Unit$394,749
U10 · FY2007 · HD · contact PI
Pediatric Pharmacology Research Unit$394,699
U10 · FY2006 · HD · contact PI
PEDIATRIC OFF-PATENT DRUGS STUDY /PODS/ CENTER FOR LORAZEPAM SEDATION--275003367$0
N01 · FY2006 · HD · contact PI
Pediatric Pharmacology Research Unit$399,172
U10 · FY2005 · HD
Pediatric Pharmacology Research Unit$387,545
U10 · FY2004 · HD
PEDIATRIC OFF-PATENT DRUGS STUDY /PODS/ CENTER FOR LORAZEPAM SEDATION-2753337C$0
N01 · FY2004 · HD
PEDIATRIC OFF-PATENT DRUGS STUDY /PODS/ CENTER FOR LORAZEPAM SEDATION-2753367C$0
N01 · FY2004 · HD
PEDIATRIC PHARMOCOLOGY RESEARCH UNIT$399,197
U01 · FY2003 · HD
PEDIATRIC PHARMOCOLOGY RESEARCH UNIT$442,835
U01 · FY2002 · HD
Aripiprazole to Control Effects of TBI in Children (ACT)$206,806
R21 · FY2002 · HD
PEDIATRIC PHARMOCOLOGY RESEARCH UNIT$179,672
U01 · FY2002 · HD
PEDIATRIC PHARMOCOLOGY RESEARCH UNIT$177,205
U01 · FY2002 · HD
Famotidine in children with renal insufficiency$0
M01 · FY2002 · RR
R108512 SOLUTION IN PEDIATRIC SUBJECTS W/ FUNCTIONAL FECAL RETENTION$0
M01 · FY2002 · RR
PEDIATRIC PHARMOCOLOGY RESEARCH UNIT$348,057
U01 · FY2001 · HD
Aripiprazole to Control Effects of TBI in Children (ACT)$214,877
R21 · FY2001 · HD
PEDIATRIC PHARMACOLOGY RESEARCH UNIT$53,559
U01 · FY2001 · HD
Famotidine in children with renal insufficiency$0
M01 · FY2001 · RR
R108512 SOLUTION IN PEDIATRIC SUBJECTS W/ FUNCTIONAL FECAL RETENTION$0
M01 · FY2001 · RR
PEDIATRIC PHARMOCOLOGY RESEARCH UNIT$368,207
U01 · FY2000 · HD
RIDOGREL IN CLINICALLY STABLE, NON ACTIVE ULCERATIVE COLITIS PEDS PAT$19,199
M01 · FY2000 · RR
R108512 SOLUTION IN PEDIATRIC SUBJECTS W/ FUNCTIONAL FECAL RETENTION$19,199
M01 · FY2000 · RR
Famotidine in children with renal insufficiency$0
M01 · FY2000 · RR